Purchase Order 75N93019P00314
- Not listed
- The U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), awarded a one-year, firm-fixed-price purchase order to Maxcyte, Inc. for the lease of one MaxCyte® GT Flow Transfection System, valued at $100,000.00. The equipment will be used to support biomedical research at the agency's facilities in Bethesda, Maryland. This award is not associated with a larger contract vehicle and does not utilize a set-aside designation. Maxcyte, Inc. is...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm-fixed-price purchase order contract to Maxcyte, Inc., a small business, for the procurement of a MaxCyte ATX Scalable Transfection System with software licenses. The contract has a potential value of $50,069.70 and was awarded on March 18, 2019 with a completion date of June 2, 2019. The award was made on a sole-source basis under the...
- This is a federal contract award by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Maxcyte, Inc. for a Transfection System. The contract has a firm fixed price of $81,385.00 and was awarded on August 8, 2018 with a completion date of September 7, 2018. The award was made without a set-aside. Maxcyte, Inc. is a commercial cell engineering company that has previously provided specialized laboratory equipment...
- Maxcyte, Inc. was awarded a firm fixed price purchase order totaling $475,000 by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases. The contract is for a one year lease of one Maxcyte GT Flow Transfection System including licensing, software, on-site upgrade, maintenance, training of NIH staff, and service. Performance will take place in Potomac, Maryland. No set-aside was used for this award. As the prime contractor,...
- The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $59,500 purchase order to Maxcyte, Inc. to acquire a MaxCyte ATX Scalable Transfection System, along with processing assemblies and software licenses. The non-competitive award was justified as Maxcyte's proprietary electroporation technology is necessary to allow for the manipulation of transcription factor protein expression. The purchase...
- The National Institutes of Health Clinical Center, within the Department of Health and Human Services, awarded a $126.3K firm fixed-price purchase order to Maxcyte, Inc. for the procurement and installation of a MaxCyte ExPERT GTx Electroporation Device along with Installation Qualification and Operational Qualification (IQ/OQ) services. The contract, awarded on March 24, 2026, with completion targeted for April 23, 2026, will be performed at the NIH Clinical Center in Bethesda, Maryland. This...
- The National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, awarded a $55,200.00 firm fixed price purchase order to Maxcyte, Inc., a for-profit corporate entity based in Rockville, Maryland. The contract is for the procurement of an EXPERT ATX Electroporation Platform, Generation 3 with accessories, to be used for developing gene editing tools for in vivo gene therapy research. This specialized laboratory equipment supports the agency's...
- The Department of Veterans Affairs Veterans Health Administration awarded a $165,000.00 firm fixed price purchase order to Maxcyte, Inc., a leading commercial cell engineering company, for the provision of specialized laboratory equipment and technologies. This contract, which did not utilize a set-aside designation, is for the delivery of transfection systems to support the agency's biomedical research and clinical care missions. Through past prime federal contract awards, Maxcyte has...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The $14,577 firm-fixed-price purchase order is for the supply of microbeads and columns for the MACS cell separation system, which is used to support biomedical research and cell therapy development programs at the NIH Clinical Center. This award is part of a larger indefinite...
- This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company. The contract, valued at $5,550.00, is for the delivery and installation of specialized laboratory equipment and related reagents and consumables. This includes flow cytometers, cell sorters, tissue dissociators, and automated cell separation systems, as well as proprietary reagents and...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a leading commercial cell engineering company, for the delivery of a PROCESSING ASSEMBLY, CL-1.1 3.5-ML (REAGENTS). The firm fixed price contract, with a potential value of $12,130.00, has an award date of February 15, 2019 and a completion date of April 19, 2019. There was no set-aside used for this contract award. Maxcyte, as the prime contractor, has a history of providing specialized laboratory equipment and technologies, such as cell processing systems, electroporation and scalable transfection systems, and related consumables and maintenance services, to support the biomedical research and regulatory missions of federal agencies including the NIH, FDA, and VA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 2/15/19 |